These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 870870)

  • 1. Metabolic studies on two patients with nonhepatic tyrosinemia using deuterated tyrosine loads.
    Faull KF; Gan I; Halpern B; Hammond J; Im S; Cotton RG; Danks DM; Freeman R
    Pediatr Res; 1977 May; 11(5):631-7. PubMed ID: 870870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    Pediatr Res; 1983 Feb; 17(2):92-6. PubMed ID: 6828337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolism of the phenolic acids in hereditary tyrosinemia by a gas-liquid chromatographic method.
    Gentz J; Lindblad B; Lindstedt S; Zetterström R
    J Lab Clin Med; 1969 Aug; 74(2):185-202. PubMed ID: 5799507
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism.
    Curtius HC; Völlmin JA; Baerlocher K
    Clin Chim Acta; 1972 Mar; 37():277-85. PubMed ID: 5022091
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary phenolic acids in tyrosinemia. Identification and quantitation by gas chromatography-mass spectrometry.
    Crawhall JC; Mamer O; Tjoa S; Claveau JC
    Clin Chim Acta; 1971 Aug; 34(1):47-54. PubMed ID: 5118727
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine.
    Wadman SK; Duran M; Ketting D; Bruinvis L; van Sprang FJ; Berger R; Smit GP; Steinmann B; Leonard JV; Divry P; Farriaux JP; Cartigny B
    Clin Chim Acta; 1983 May; 130(2):231-8. PubMed ID: 6872257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some biochemical effects of chloral hydrate in an infant with a tyrosinemia-like syndrome.
    Watts RW; Chalmers RA; Liberman MM; Lawson AM
    Pediatr Res; 1975 Dec; 9(12):875-8. PubMed ID: 1196703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic studies of transient tyrosinemia in premature infants.
    Fernbach SA; Summons RE; Pereira WE; Duffield AM
    Pediatr Res; 1975 Apr; 9(4):172-6. PubMed ID: 1143952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parahydroxyphenylpyruvicacidemia in tyrosinosis.
    Jaiswal RB; Bhai I; Daginawala HF; Nath N; Nath MC
    Indian Pediatr; 1978 Nov; 15(11):893-9. PubMed ID: 36347
    [No Abstract]   [Full Text] [Related]  

  • 10. Tyrosine metabolism in cirrhosis.
    Nordlinger BM; Fulenwider JT; Ivey GL; Faraj BA; Ali FM; Kutner M; Henderson JM; Rudman D
    J Lab Clin Med; 1979 Dec; 94(6):832-40. PubMed ID: 501206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.
    Tomoeda K; Awata H; Matsuura T; Matsuda I; Ploechl E; Milovac T; Boneh A; Scott CR; Danks DM; Endo F
    Mol Genet Metab; 2000 Nov; 71(3):506-10. PubMed ID: 11073718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
    Michals K; Matolon R; Wong PW
    J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The investigation of aromatic acids in phenylketonuria, alkaptonuria and tyrosinosis using gas-liquid chromatography.
    Hill A; Hoag GN; Zaleski WA
    Clin Chim Acta; 1972 Mar; 37():455-62. PubMed ID: 5022110
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
    Ellis MK; Whitfield AC; Gowans LA; Auton TR; Provan WM; Lock EA; Smith LL
    Toxicol Appl Pharmacol; 1995 Jul; 133(1):12-9. PubMed ID: 7597701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent tyrosinemia associated with low activity of tyrosine aminotransferase.
    Andersson S; Nemeth A; Ohisalo J; Strandvik B
    Pediatr Res; 1984 Jul; 18(7):675-8. PubMed ID: 6147810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital disorders of tyrosine metabolism and their correction in children with tumors].
    Baĭkova VN; Vares IM; Rybal'chenko VG; Shevchenko VE; Sotnikova EN
    Vopr Onkol; 1987; 33(11):42-8. PubMed ID: 3686921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical study of malnutrition. Part V. Metabolism of phenylalanine and tyrosine.
    Antener I; Verwilghen AM; van Geert C; Mauron J
    Int J Vitam Nutr Res; 1981; 51(3):297-306. PubMed ID: 6119298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of hydroxyphenylpyruvic acid, hydroxyphenyllactic acid and tyrosine on routine serum and urine clinical chemistry assays; implications for biochemical monitoring of patients with alkaptonuria treated with nitisinone.
    Curtis SL; Norman BP; Milan AM; Gallagher JA; Olsson B; Ranganath LR; Roberts NB
    Clin Biochem; 2019 Sep; 71():24-30. PubMed ID: 31228435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin of urinary p-hydroxyphenylpyruvate in a patient with hepatic cytosol tyrosine aminotransferase deficiency.
    Kennaway NG; Buist NR; Fellman JH
    Clin Chim Acta; 1972 Oct; 41():157-61. PubMed ID: 4405100
    [No Abstract]   [Full Text] [Related]  

  • 20. Deranged tyrosine metabolism in cirrhosis.
    Fulenwider JT; Nordlinger BM; Faraj BA; Ivey GL; Rudman D
    Yale J Biol Med; 1978; 51(6):625-33. PubMed ID: 36717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.